Member Log-in

I forgot my password

Not a Member? Register

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more support from a total of up to US$ 200 million is likely to be approved in the coming days and weeks. This early funding is designed to provide immediate support until more substantial support from other sources is unlocked.

 

Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

LNCT Member Newsletter February 2021

LNCT UPDATES NEW LNCT BRIEF: Mobilizing Resources for Immunization in Decentralized Health Systems National immunization programs and immunization partners may need to consider new strategies to mobilize sufficient funding for immunization at subnational levels. This new LNCT brief outlines some of the key challenges found across LNCT countries with decentralized systems and offers several promising strategies for NIPs to … Continued

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Continued

LNCT Member Newsletter July 2020

LNCT Updates Materials from Two Recent LNCT Webinars Now Available Online On June 23, LNCT held a webinar, Assessing Bottlenecks to Adequate and Predictable Vaccine Financing. The World Bank presented their tool which aims to help country counterparts pinpoint the root causes of bottlenecks that affect adequate and reliable vaccine financing. The materials from the webinar, including … Continued

Choose a Language